Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G FORNI

Showing results (301-310 of 326) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical TrialRinaldo Bellomo, Lui G Forni, Laurence W Busse, et al.
Journal of Critical Care|December 24, 2017
Pragmatic studies for acute kidney injury: Consensus report of the Acute Disease Quality Initiative (ADQI) 19 WorkgroupZhiyong Peng, Kaijiang Yu, Marlies Ostermann, et al.
Chest|May 1, 2020
Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical TrialIvor S Douglas, Philip M Alapat, Keith A Corl, et al.
Methods of Information in Medicine|June 1, 2005
GPCALMA: a Grid-based tool for mammographic screeningP Cerello, S Bagnasco, U Bottigli, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Renal Failure|April 26, 2024
Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meetingJay L Koyner, Christian Arndt, Jaume Baldira Martinez de Irujo, et al.
Intensive Care Medicine|February 7, 2020
Identification and validation of biomarkers of persistent acute kidney injury: the RUBY studyEric Hoste, Azra Bihorac, Ali Al-Khafaji, et al.
Pageof 33

Showing results (301-310 of 326) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical TrialRinaldo Bellomo, Lui G Forni, Laurence W Busse, et al.
Journal of Critical Care|December 24, 2017
Pragmatic studies for acute kidney injury: Consensus report of the Acute Disease Quality Initiative (ADQI) 19 WorkgroupZhiyong Peng, Kaijiang Yu, Marlies Ostermann, et al.
Chest|May 1, 2020
Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical TrialIvor S Douglas, Philip M Alapat, Keith A Corl, et al.
Methods of Information in Medicine|June 1, 2005
GPCALMA: a Grid-based tool for mammographic screeningP Cerello, S Bagnasco, U Bottigli, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Renal Failure|April 26, 2024
Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meetingJay L Koyner, Christian Arndt, Jaume Baldira Martinez de Irujo, et al.
Intensive Care Medicine|February 7, 2020
Identification and validation of biomarkers of persistent acute kidney injury: the RUBY studyEric Hoste, Azra Bihorac, Ali Al-Khafaji, et al.
Pageof 33